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Abstract
Background: Chemical bonding of the drug onto surfaces by means of spacer molecules is
accompanied with a reduction of the biological activity of the drug due to a constricted mobility
since normally only short spacer molecule like aminopropyltrimethoxysilane (APMS) are used for
drug coupling. This work aimed to study covalent attachment of heparin to titanium(oxide) surfaces
by varying the length of the silane coupling agent, which should affect the biological potency of the
drug due to a higher mobility with longer spacer chains.
Methods: Covalent attachment of heparin to titanium metal and TiO2 powder was carried out
using the coupling agents 3-(Trimethoxysilyl)-propylamine (APMS), N- [3-
(Trimethoxysilyl)propyl]ethylenediamine (Diamino-APMS) and N1- [3-(Trimethoxy-silyl)-
propyl]diethylenetriamine (Triamino-APMS). The amount of bound coupling agent and heparin was
quantified photometrically by the ninhydrin reaction and the tolidine-blue test. The biological
potency of heparin was determined photometrically by the chromogenic substrate Chromozym
TH and fibrinogen adsorption to the modified surfaces was researched using the QCM-D (Quartz
Crystal Microbalance with Dissipation Monitoring) technique.
Results: Zeta-potential measurements confirmed the successful coupling reaction; the potential of
the unmodified anatase surface (approx. -26 mV) shifted into the positive range (> + 40 mV) after
silanisation. Binding of heparin results in a strongly negatively charged surface with zeta-potentials
of approx. -39 mV. The retaining biological activity of heparin was highest for the spacer molecule
Triamino-APMS. QCM-D measurements showed a lower viscosity for adsorbed fibrinogen films on
heparinised surfaces by means of Triamino-APMS.
Conclusion: The remaining activity of heparin was found to be highest for the covalent attachment
with Triamino-APMS as coupling agent due to the long chain of this spacer molecule and therefore
the highest mobility of the drug. Furthermore, the adsorption of fibrinogen on the differently
heparinised surfaces in real time demonstrated that with longer spacer chains the ∆D/∆f ratios
became higher, which is also associated with better biocompatible properties of the substrates in
contact with a biosystem.
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Background
Cardiovascular diseases determined by arteriosclerosis are
the main cause of death in developed nations [1]. Since
surgical interventions strongly stress the patient's organ-
ism, modern minimal invasive methods have become
more and more important [2]. During the last two dec-
ades, intravascular coronary stent implantation at the site
of acute artery closure has been widely used and has
increased the quality of life and life expectancy of patients
with coronary diseases. This type of surgery has proved
effective in restoring vessel potency and decreasing myo-
cardial ischemia. 316L stainless steel and titanium(alloys)
are widely used in the fabrication of coronary stents
because of their electrochemical and mechanical proper-
ties [3]. However, the exposure to blood flow can result in
thrombus formation and smooth muscle cell prolifera-
tion, which both ultimately lead to restenosis. To avoid
thrombus formation, aggressive anticoagulants are sys-
temically applied, however, this can cause bleeding disor-
der in long-term application. Thus, a great amount of
recent work has attempted to develop non-thrombogenic
coatings for these metallic stents, e.g. by chemical cou-
pling of antithrombogenic drugs (heparin, heparan sul-
fate) to the surface [4,5].
This work aimed to investigate the influence of different
coupling agents with varying chain length on the amount
and biological performance of surface bound heparin.
The principle of the surface modification is demonstrated
in Figure 1a for 3-(Trimethoxysilyl)-propylamine (APMS)
as commonly used spacer. Alternative coupling agents
(Figure 1b) with two or three amino-moieties were N- [3-
(Trimethoxysilyl)propyl]ethylenediamine (Diamino-
APMS) and N1- [3-(Trimethoxysilyl)-propyl]diethylene-
triamine (Triamino-APMS). Surface modification was per-
formed using both TiO2 powder and titanium sheets as
substrates. The coupling reaction was followed by means
of zeta-potential measurements and the amount of sur-
face bound spacer and heparin and their hydrolytic stabil-
ity was quantified via the ninhydrin and the toluidine-
blue reaction. Determination of the biological activity of
the immobilised heparin was performed with the chro-
mogenic substrate Chromozym TH test. Fibrinogen
adsorption to the modified surfaces was followed in real




Titanium dioxide (anatase) was purchased from Merck
(Darmstadt, Germany). The coupling agents 3-(Trimeth-
oxysilyl)-propylamine,  N- [3-(Trimethoxysilyl)pro-
pyl]ethylenediamine and N1- [3-(Trimethoxysilyl)-
propyl]diethylenetriamine were obtained from Merck
(Darmstadt, Germany), Fluka (Buchs, Schwitzerland) and
Aldrich (Steinheim, Germany). N-(3-Dimethylaminopro-
pyl)-N'-ethylcarbodiimide Hydrochloride(EDC) was pur-
chased from Sigma Chemical Company. N-
Hydroxysuccinimide (NHS) was purchased from Merck.
2-(N-Morpholino)ethanesulfonic acid (MES) and
Heparin Sodium salt were purchased from Fluka (Buchs,
Schwitzerland).
Silanisation of titanium dioxide and cp-titanium
Modification of TiO2 was carried out under variation of a
published preparation regime [6]. 2.00 g TiO2  (25.0
mmol) and 2.00 ml 3-(Trimethoxysilyl)-propylamine
(APMS, 11.3 mmol) were suspended under argon atmos-
phere in 50.0 ml anhydrous toluene following 2 h treat-
ment with ultrasound (35 kHz, Sonorex RK 102, Fa.
Bandelin, Berlin). Afterwards, the functionalised TiO2 was
separated with a G4-frit from the solution, washed with
toluene and then purified with ethyl acetate in a Soxleth-
extractor for 2 h. Finally, the sample was dried in vacuum
at room temperature. The reaction was alternatively per-
formed with 2.46 ml N- [3-(Trimethoxysilyl) propyl]eth-
ylenediamine (Diamino-APMS, 11.3 mmol) or 2.91 ml
N1- [3-(Trimethoxysilyl)-propyl]diethylenetriamine (Tri-
amino-APMS, 11.3 mmol).
cp-Titanium surfaces were modified in a similar manner.
The substrates (d = 16 mm, h = 1 mm; Zapp, Düsseldorf)
were firstly cleaned in 5% EXTRAN solution for 10 min
using ultrasound following three washes with deionised
water. Oxidation of the metal surface to produce a homo-
geneous oxide layer was either performed by using a solu-
tion of conc. H2SO4/30% H2O2 (1:1) for 3.5 h at room
temperature or thermally by annealing the substrates at
750°C for 90 min in a furnace. These samples were then
boiled in a solution of 7.00 ml APMS (39.7 mmol) in 70
ml toluene for 6 h.
a) Reaction scheme of the immoblilisation of heparin on tita- nia by dint of APMS and b) further spacer molecules used as  coupling agents for heparin Figure 1
a) Reaction scheme of the immoblilisation of heparin on tita-
nia by dint of APMS and b) further spacer molecules used as 
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Covalent attachment of heparin
In each case 500 mg of the functionalised TiO2 was sus-
pended in 50.0 ml MES-buffer (50.0 mM, 40% (v/v) ethyl
alcohol/water, pH = 5.5) and stirred for 15 min. Then,
95.0 mg N-(3-Dimethylaminopropyl)-N'-ethylcarbodi-
imide Hydrochloride (EDC, 0.50 mmol), 12.0 mg N-
Hydroxysuccinimide (NHS, 0.10 mmol) and 100 mg
heparin (~5.60 µmol) were added to the suspensions fol-
lowed by stirring the reaction mixture at room tempera-
ture for 6 h. Finally, the solid was separated by
centrifugation and the obtained modified powders were
washed three times each with Na2HPO4-solution (0.10
M), NaCl-solution (2.00 M), deionised water and then
dried in vacuum at 40°C over night. The modification of
APMS modified titanium substrates with heparin was per-
formed in a similar manner by stirring the metal samples
in a solution of 19.0 mg EDC (0.10 mmol), 2.00 mg NHS
(0.02 mmol) and 20.0 mg heparin in 50 ml MES-buffer
for 6 h at room temperature.
Quantification of surface bound spacer and heparin
The quantification of the spacer was determined by the
amount of terminal primary amino groups and could be
measured photometrically by dint of the ninhydrin reac-
tion after Moore and Stein [7-9]. Basically, this method is
based upon the reaction of primary amino groups with
ninhydrin to give the dye "Ruhemanns Purpur", which
can be quantified photometrically at 570 nm. The amount
of immobilised heparin was quantified by means of the
toluidine-blue method, already described in literature
[10]. This method is based on complexation of the dye
toluidine blue with heparin in aqueous medium. By the
use of an excess of the dye, the residual "free" toluidine-
blue can be determined photometrically at 631 nm and
can be correlated with the amount of immobilised
heparin.
Hydrolysis behaviour of immobilised heparin
Five probes with 250 mg of the TiO2 powders, respec-
tively, modified with APMS, Di- and Triamino-APMS and
heparin were given in glass flasks. Then, 5.00 ml PBS
buffer was added and the suspensions were treated with
ultrasound for 3 min. The flasks were densely closed with
a plastic lid and then given inside an incubator (37°C)
onto a shaker (70 shakes per minute). At scheduled times
one probe of each heparinised samples was taken, the
powder was separated from the liquid with a centrifuge
and then dried in vacuum. The amount of residual immo-
bilised heparin was quantified photometrically with the
toluidine-blue method.
Determination of the biological potency of heparin
For the determination of the biological activity of the
immobilised heparin, the chromogenic substrate Chro-
mozym TH was used. The principle of this method is
based upon heparin formation with antithrombin (AT-
III), a heparin/AT-III-complex in an aqueous medium. In
the presence of an excess of thrombin, formation of a
heparin/AT-III/thrombin-complex follows. Excessive
thrombin in solution catalyses the hydrolysis of the chro-
mogenic substrate Chromozym TH into a dye, which can
be measured photometrically at 405 nm [11]. The higher
the biological activity of the heparin remains after
immoblisation, the more thrombin is complexed and the
less dye will be hydrolysed.
Surface charge (Zeta-potential) of modified surfaces
Zeta potentials were measured with a Zeta-sizer 3000
(Malvern Instruments, Herrenberg, Germany) equipped
with a HeNe-Laser (λ = 633 nm) and a standard electro-
phoresis cell at an electrical field force of ± 150 mV. The
suspension medium was double distilled water. For data
compilation the software PCS version 1.36 from Malvern
Instruments, Herrenberg was used.
Fibrinogen adsorption to modified surfaces
The adsorption of fibrinogen onto the modified surfaces
was measured in real-time using Quartz Crystal Microbal-
ance with Dissipation Monitoring (QCM-D; Q-Sense,
D300, Sweden). Modification of the quartz crystals was
performed in three steps: firstly a thin TiO2 coating was
applied using physical vapour deposition (PVD) tech-
nique [12] following chemical coupling of APMS,
Diamino-APMS and Triamino-APMS and heparin similar
to the methods described for cp-titanium samples. Fibrin-
ogen adsorption was measured at room temperature using
5.00 ml of a solution of fibrinogen dissolved in phosphate
buffered saline (PBS, 50.0 µg fibrinogen/ml PBS) for
about 5 h. The adsorbed mass of fibrinogen on the differ-
ently heparinised surfaces was calculated according to the
Sauerbrey equation, where the change in the resonance
frequency ∆f is proportional to the change in the adsorbed
mass ∆m:
with n being the number of the overtone (= 3) of the
measured frequency and C = 17.7 ng/cm2Hz for the crys-
tals used in this experiment [13].
Results
Chemical coupling of silane spacers and heparin to TiO2
was followed by measuring the zeta-potentials from the
unmodified, with spacer functionalised or rather
heparinised powders (Figure 2). Unmodified TiO2 had a
negative zeta potential of -26.1 ± 10.5 mV due to its
deprotonated hydroxyl groups at pH 7 in water. After
modification with the different spacer molecules, the zeta-




f =− (1)BioMedical Engineering OnLine 2007, 6:31 http://www.biomedical-engineering-online.com/content/6/1/31
Page 4 of 8
(page number not for citation purposes)
40.6 ± 6.2 mV (Diamino-APMS) and 45.3 ± 5.5 mV (Tri-
amino-APMS), due to protonated primary amino groups
(RNH3 
+) of the spacer molecules in water. Finally, the
covalent attachment of heparin changes the zeta-poten-
tials to negative values of -37.2 ± 0.9 mV (APMS), -39.3 ±
1.0 mV (Diamino-APMS) and 39.0 ± 0.2 mV (Triamino-
APMS). The strong decrease of the zeta-potentials is
caused by negative sulphate and carboxyl groups of the
drug in the aqueous medium at pH 7.
The amount of covalently attached primary amino groups
on the titania surface (powder and metal sheets) was
determined photometrically by the ninhydrin reaction
and is shown in Table 1. The amount of immobilised ter-
minal amino groups on TiO2 powder was the highest for
APMS and decreased for Di- and Triamino-APMS.
Quantification of immobilised heparin was done by the
toluidine-blue method and was only applicable for the
drug modified powders (Table 2). On the Ti discs, no
heparin was detectable by this method, probably because
the amount of bound drug was less than the detection
limit of 10 µg by this method. On the APMS spacer, the
greatest amount of 53.3 ± 3.6 ng/cm2 heparin was
attached compared to Di- and Triamino-APMS (Table 2).
The potency of the immobilised heparin was measured
photometrically by dint of the chromogenic substrate
Chromozym TH at λ = 405 nm. Comparing the potencies
of the covalently attached heparin on Di- and Triamino-
APMS with APMS, it becomes obviously that longer spacer
molecules tend to result in higher biological activity of
heparin (Figure 3). The influence of the secondary amino
groups on the immobilisation of heparin was investigated
by measuring the hydrolysis rate of the drug under in vitro
simulated physiological conditions (37°C, PBS, 70 shakes
per minute). Figure 4 shows that spacers like Triamino-
APMS with many secondary amino groups has the highest
hydrolysis rate of the drug during the first 100 h, com-
pared to Diamino-APMS and APMS.
Figure 5 shows changes of the frequency ∆f and the dissi-
pation ∆D for the various surfaces during QCM-D meas-
urement. The addition of fibrinogen dissolved in PBS
buffer occurred after 5 min and resulted in a decrease of ∆f
and an increase of ∆D. Since ∆f correlates with a mass
increase of the crystal due the adsorbed protein layer and
∆D depends on the viscoelastic properties of the layer, the
results demonstrate that the amount of adsorbed fibrino-
gen varied in the range APMS > Diamino-APMS > Tri-
amino-APMS for the differently heparinised surfaces. The
amount of adsorbed protein was calculated to be 539 ng/
cm2 (APMS), 476 ng/cm2 (Diamino-APMS) and 382 ng/
cm2 (Triamino-APMS) after 5 h adsorption time using the
Sauerbrey equation. The adsorbed protein layers showed
different viscoelastic properties as seen by the dissipation
curves, the layer viscosity increased in the range APMS <
Triamino-APMS < Diamino-APMS.
Discussion
The covalent coupling of heparin to titanium dioxide was
realised in this study by spacers with different chain
lengths like APMS, Di- and Triamino-APMS (Figure 1).
The hypothesis was, that the use of longer spacer chains
should result in a higher mobility of immobilised heparin
and hence a higher biological potency of the drug. Cou-
pling of heparin to the spacer modified surfaces was per-
formed following activation of carboxylic groups with
EDC and NHS, which then react with primary amino
Table 2: Quantification of heparin immobilised on APMS, Di- and 
Triamino-APMS modified titania powders
APMS Diamino-APMS Triamino-APMS
[ng/cm2] 53.3 ± 3.6 41.2 ± 6.9 32.1 ± 5.7
Zeta potentials after functionalisation of TiO2 powder with  APMS, Di- and Triamino-APMS and respectively after the  reaction with heparin Figure 2
Zeta potentials after functionalisation of TiO2 powder with 
APMS, Di- and Triamino-APMS and respectively after the 
reaction with heparin. Each data point is the mean of three 
samples, error bars are standard deviations.
Table 1: Quantification of NH2 groups per area for different 
spacer molecules on cp-titanium and on TiO2 powder (amount 
per powder weight in [nmol/mg] in parenthesis)




cp-Ti disc 156 ± 16 162 ± 12 134 ± 22
TiO2 powder 20.0 ± 0.5 
(84.9 ± 2.1)
18.7 ± 0.5 
(78.7 ± 2.0)
17.0 ± 0.3 (71.3 ± 1.3)BioMedical Engineering OnLine 2007, 6:31 http://www.biomedical-engineering-online.com/content/6/1/31
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groups of the spacer molecules (Figure 1a), whereas the
secondary amino groups (R-NH-R') are not able to form
amide bonds with carboxyl groups. The successful modi-
fication of TiO2 surfaces with coupling agent and heparin
was demonstrated by measuring zeta-potential changes in
aqueous solution (Figure 2) since both the spacer as well
as the drug led to a change of the potential due to charged
amino and sulphate groups in the modification.
Although this reaction took place for all three coupling
agents, the amount of immobilised spacer and drug was
significantly different in the order APMS > Diamino-
APMS > Triamino-APMS. This phenomenon can be
explained, since the larger molecules like Triamino-APMS
are sterically more hindered on the titania surface than the
smaller ones. Furthermore, a higher number of secondary
amino groups result in a stronger intermolecular electro-
static repulsion. Both effects lead to less pronounced dep-
osition of spacer molecules on the surface. Comparing the
values of Table 1 with those of the literature, where a
monolayer of NH2 groups is described with 2–3 NH2/
nm2, the here accomplished aminations are in the range
of multilayers [14]. Furthermore, the number of amino
groups on Ti discs was multiple higher than those on the
powders (Table 1). However, calculating the surface area
of the discs, ideally plane surfaces were supposed, whereas
the high micro roughness of the real surface and hence a
higher actual surface area was not considered.
A similar behaviour was found for the amount of immo-
bilised heparin which subsequently decreased with
increasing the length of the spacer (Table 2). This corre-
lates with the highest density of surface bound primary
amino groups of APMS that can form bonds with carbox-
ylic groups of the heparin. If the amount of attached
heparin is compared with literature values for heparin
modified polymers [15-17] (Table 3), the here obtained
values are much lower. This is probably due to the fact,
that polymers can bind heparin over their whole volume
what can be considered as a heparinisation in the range of
many multilayers. Although the amount of immobilised
heparin was lower for Triamino-APMS, this coupling
agent showed the highest biological potency of the cova-
lently attached drug (Figure 3), which confirmed our
hypothesis that longer spacer chains will maintain the
∆f (decreasing curves) and ∆D (increasing curves) of the  adsorption of fibrinogen on surfaces functionalised with  APMS/Di/Tri(amino-)APMS and Hep(arin) in real-time Figure 5
∆f (decreasing curves) and ∆D (increasing curves) of the 
adsorption of fibrinogen on surfaces functionalised with 
APMS/Di/Tri(amino-)APMS and Hep(arin) in real-time.
Remaining potencies of heparin immobilised by the spacers  APMS, Di- and Triamino-APMS Figure 3
Remaining potencies of heparin immobilised by the spacers 
APMS, Di- and Triamino-APMS. Each data point is the mean 
of three samples and error bars are standard deviations.
Hydrolysis of heparin from the spacer molecules APMS, Di-  and Triamino-APMS in aqueous medium Figure 4
Hydrolysis of heparin from the spacer molecules APMS, Di- 
and Triamino-APMS in aqueous medium. Each data point is 
the mean of three samples and error bars are standard devi-
ations.BioMedical Engineering OnLine 2007, 6:31 http://www.biomedical-engineering-online.com/content/6/1/31
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biological activity of the material due to a higher flexibil-
ity of the immobilised heparin.
The influence of the secondary amino groups on the sta-
bility of heparin immobilisation was investigated by
measuring the hydrolysis rate of the drug under in vitro
simulated physiological conditions (37°C, PBS, 70 shakes
per minute) (Figure 4). In an aqueous medium, these sec-
ondary amino groups are protonated to R2NH2 
+, which
makes them able to interact with negative sulphate, car-
boxylate and hydroxyl groups of the heparin via electro-
static interactions. This ionic bonding is weaker than the
covalent one and should have only an additional effect. It
was shown that spacers like Triamino-APMS with many
secondary amino groups had the highest hydrolysis rate of
the drug during the first 100 h, compared to Diamino-
APMS and APMS. This effect is up to heparin molecules
that are only bound electrostatically, which makes the
hydrolysis easier and faster. After this period, the hydroly-
sis profile inverses and the drug hydrolysed slower from
Triamino-APMS than from the other ones. The reason
probably is, that the remaining heparin molecules are
both covalently and ionically bound on the Triamino-
APMS compared to pure APMS that can only bind the
drug covalently.
The primary reaction after incorporating an implant into
the body is the formation of a biofilm composed of
adsorbed matrix proteins. The quantitative composition
of this protein film and conformational changes during
adsorption are thought to be the key factor controlling the
attachment of cells and the biological response to the
implant material [18]. In case of materials in contact with
blood, it is also known that the adsorption of various pro-
teins combined with structural changes of the protein
layer, e.g. fibrinogen can initiate blood clothing. The
adsorption of fibrinogen to heparinised TiO2 surfaces was
measured in this study using the QCM-D technique. The
QCM-D method offers two advantages, firstly, the adsorp-
tion can be followed in real-time due to the mass increase
of the quartz crystal and secondly, it is possible to analyse
conformational changes due to the viscoelastic properties
of the adsorbed protein layer. Therefore, the gold surfaces
of the quartz crystals were modified in a first step with a
thin (approx. 100 nm) TiO2 layer using the PVD tech-
nique which were then coated with the coupling agents
APMS/Di-/Triamino-APMS and heparin similar to the
methods described for titanium substrates. The concentra-
tion of the extracellular plasma protein fibrinogen (in
PBS, pH = 7.4) used was 50.0 µg/mL. Although this was
much lower compared to that of human blood (3 mg/
mL), this lower concentration allows single fibrinogen
molecules to interact with the surface, before the surface
area around the protein is blocked by newly adsorbed
fibrinogen molecules. The resulting two effects are firstly
a tight bound layer of fibrinogen which contains less
water, whereby the effect of water in the protein layer dur-
ing the QCM-D measurment is reduced. Secondly, lower
protein concentrations (< 50 µg/ml) advance surface
effects on the protein adsorption and thus the QCM-D
measurements provide more information regarding dif-
ferently functionalised surfaces for protein adsorption
[13].
Figure 6 shows a correlation between ∆D and ∆f for the
differently heparinised surfaces which is helpful for ana-
lysing and comparing the viscoelastic properties of pro-
tein films on different surfaces since ∆f and ∆D did not
have the same time dependency such that time as param-
eter can be eliminated due to this approach. In various
experiments it was shown that a low ∆D/∆f is an indica-
tion for rigid adsorbed films [19]. The results demonstrate
that the ∆D/∆f values for surfaces modified with APMS
and heparin nearly built up a line with only a small
increase at higher frequencies. In contrast, the ratios of the
heparinised surfaces by means of Diamino-APMS and Tri-
Correlation between ∆D and ∆f of the different surfaces  from Figure 5 Figure 6
Correlation between ∆D and ∆f of the different surfaces 
from Figure 5. The ∆D/∆f values can be taken to compare 
the viscosity of protein layers adsorbed onto different sur-
faces because of elimination of the factor time.
Table 3: Amount of immobilised heparin on different polymer substrates *(dependent on PEO spacer length)
Substrate Polyurethane-CO2H Polyurethane-NH2 Polyurethane-PEO Polyethylene
Heparin [µg/cm2] 1.40 ± 0.08 2.00 ± 0.13 0.24 ± 0.04–0.47 ± 0.08* 4.4 ± 0.1–4.7 ± 0.1BioMedical Engineering OnLine 2007, 6:31 http://www.biomedical-engineering-online.com/content/6/1/31
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amino-APMS are generally higher. This behaviour indi-
cates structural changes within the adsorbed protein layer
[20].
Lower ∆D/∆f ratios for the differently heparinised surfaces
indicate a more dense package of the protein layer onto
the surfaces which is either due to conformational
changes of the adsorbed protein layer (denaturation) and/
or a high affinity of the binding sites of the protein to the
substrate. Fibrinogen is a long rod-like molecule with
three different globular sub-domains (E, D and αC
domains). Under physiological conditions the overall
charge of fibrinogen is negative. The D and E domains are
negatively charged but the αC domains are positively
charged. The αC domain acts as a pioneer in the surface
binding process, but it does not bind strongly to the sur-
face [21]. It seems certain, that the differences for the ∆D/
∆f ratios are partially caused by electrostatic interactions
between the domains of fibrinogen with the heparin and
respectively the different spacer molecules that are bound
onto the substrate.
Indeed, it could be figured out through zeta-potential
measurements that surfaces from substrates modified
with APMS, Di- and Triamino-APMS and the respective
subsequent heparinised surfaces (Figure 2) had positive
and accordingly negative charges that were all very simi-
lar. But even if these overall charges of the respective func-
tionalised surfaces are all in the same range, it is likely,
that the secondary amino groups of the spacer molecules
Di- and Triamino-APMS interact with the positively
charged αC domains of fibrinogen while adsorbing. On
the one hand, this could have an influence on the adsorp-
tion kinetics of the protein and explain, why the ∆f curves
of the haparinised surfaces by means of Di- and Triamino-
APMS are similar and arise faster compared with that of
APMS. On the other hand, this electrostatic interaction
could influence conformational changes in the adsorbed
protein layer and therefore be responsible for the highest
∆D/∆f ratio for Triamino-APMS.
It is also likely that sterical reasons are responsible for the
different ∆D/∆f ratios from Figure 6. Protein layers could
be packed denser on surfaces that were modified with the
spacer APMS with the shortest molecule chain rather than
on Di- and Triamino-APMS modified surfaces, since
APMS molecules underlie a lower sterical hindrance
among each other. This effect could result in a subsequent
denser functionalisation with heparin which finally
allows a stronger interaction of fibrinogen with the drug
and therefore a denser package, which results in lower
∆D/∆f ratios compared to the heparinisation with longer
spacer molecules like Di- and Triamino-APMS. Since a
densification of protein films is normally accompanied by
conformational changes, it is likely that these changes are
less pronounced on the Triamino-APMS surfaces com-
pared to the shorter coupling agents.
Conclusion
In this comparative study, the heparinisation of titanium
dioxide substrates by means of the spacer molecules
APMS, Di- and Triamino-APMS was investigated with
regard to the biological activity of the immobilised drug
and the adsorption of the extracellular plasma protein
fibrinogen by means of the QCM-D technique to obtain a
first impression of the biocompatibility for a possible in
vivo application. The remaining activity of heparin was
found to be highest for the covalent attachment with Tri-
amino-APMS as coupling agent due to the long chain of
this spacer molecule and therefore the highest mobility of
the drug, which allows a better interaction of heparin with
ATIII for inhibition of blood clotting. Furthermore, the
adsorption of fibrinogen on the differently heparinised
surfaces in real time demonstrated that with longer spacer
chains and accordingly increasing number of secondary
amino groups the ∆D/∆f ratios become higher, which is
also associated with a less pronounced denaturation of
the protein and thus possibly better biocompatible prop-
erties of the substrates in contact with a biosystem.
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